ʻO ke kumuhana nui o nā paona he mea kaumaha loa no ka poʻe me ka maʻi maʻi. Nui ka poʻe i ʻike e ma ka hoʻemi ʻana i ke kaumaha, hiki iā lākou ke hoʻomaikaʻi nui i ko lākou kūlana. Ma waho o ke kōkua o ka loea, a ʻaʻole hiki i nā mea āpau ke paʻakikī, e paʻakikī ke ʻimi i ka pono a me ka palekana no ka pohō ʻana, no laila ke ʻimi nei nā poʻe i nā ala maʻalahi a mālama pono i nā papa meaʻai. I kēia manawa, ʻo ke koho kūʻokoʻa i kēlā mau lāʻau lapaʻau ke hoʻopuni nui ʻia me nā pilikia olakino. Ua noi mākou i ko mākou manamana olakino endocrinologist Olga Pavlova e kamaʻilio hou aku e pili ana i ka "pills diet."
Kauka iʻa endocrinologist, ma ʻoma maʻi, ka mea ʻona, ka mea hoʻokūkū hāmeʻa Olga Mikhailovna Pavlova
Ke puka puka ʻana mai ke Kulanui Kaukaʻāina ʻo Novosibirsk (NSMU) me kahi kekeke i ʻo General Medicine me nā mea hoʻonani
Ua puka ʻo ia me nā hanohano mai ka noho ʻana i ka endocrinology ma NSMU
Ua puka ʻo ia me nā hanohano mai ka Dietology kūikawā ma NSMU.
Ua lilo ʻo ia i ka hana hoʻomau ʻana i ka hoʻomaʻamaʻa ma Sports Dietology ma ke Kulanui o ke Fitness a me ke Kino o ke Kino ma Moscow.
Lālau ʻia i ke aʻo ʻana ma ka psychocorrection o ke kaupaona ʻana.
ʻO ka maʻi mellitus ka mea he lawehala i ka metabolism o ka paʻakai, a me kahi metabolism i hoʻopalau ʻia, loaʻa ka nui o ke kaumaha he mea maʻalahi loa, ʻoiai ke alo o ka kū ʻana o ka insulin a me ka hyperinsulinemia, ʻo ia hoʻi, me ka maʻi diabetes type 2. ʻO ka maʻi maʻi maʻi maʻi ʻōpala 1 hoʻi pinepine ʻia nā mea momona kiʻekiʻe. Me ka maʻi maʻamau 1, koi ʻia ka hana ʻana i ka insulin a hiki i ka papaʻai ʻana i ka ʻai ke hiki i ka hypoglycemia (ke kahe ʻana o ke kō koko koko), no laila, ʻo ka poʻe maʻi, e makaʻu ana i kēia ʻano, pinepine ka nui, a me ka pale ʻana ma ke ʻano o ka insulin insulin he ala pololei i ka hiʻona.
Hoʻomaʻ pinepine pinepine nā mea maʻi me ka maʻi mellitus i ka hōʻola ʻana i nā mea ʻaina a me ka papa ʻaina ʻole e kōkua, a koi iā lākou e kuhikuhi i "nā lāʻauʻai meaʻai", i hoʻohui pinepine ʻia: "ʻO nā paila a like ʻole (ka inoa), ua nalowale kaʻu kāpena he 10-20-30 kg ma luna o lākou a makemake no hoi au ia. " ʻAʻole noʻonoʻo ka hapa nui o ka poʻe i ka lāʻau lapaʻau no ka hoʻolilo ʻana o ka mea momona, ʻoi aku ka ikaika o nā lāʻau lapaʻau ikaika, e hōʻike pono ana i nā maʻi, contraindications, nā hana a me nā hopena like, a hiki i nā mea maʻi me ka maʻi maʻi maʻi lā e hōʻike ikaika loa. A ʻo kēlā mau mākela mana, kahi i nalowale ai ke kauā o ka mea maʻi a he koʻikoʻi nui a ka mea maʻi i hōʻeha i kā mākou mea maʻi.
I kēia lā ke kūkākūkā mākou i nā lāʻau lapaʻau no ka mea luhi.
Inā mākou e noʻonoʻo i nā kūlana olakino no ka mālama ʻana i ka momona, a ma ka manawa like he 4 mau pūʻulu o nā lāʻau lapaʻau e hoʻohana mana ʻia e hōʻemi i ke kaumaha o ke kino ma ka Russian Federation. Ma kēiaʻatikala, ʻaʻole wau e noʻonoʻo i ka mea hoʻolako meaʻaiʻai a me nā lako hāmeʻa - ke ʻōlelo nei mākou e pili ana i nā lāʻau lapaʻau i ʻāpono ʻia me kahi hopena hōʻoia.
KAHAKAI! ʻO nā lāʻau lapaʻau no ka hoʻolimalima ʻana i ke koikoi he nui nā contraindications a me nā hopena ʻaoʻao a ke kau wale ʻia e nā kauka ma hope o kahi hoʻopaʻa ʻana o ke kino.
No ka mea he diabetes mellitus, inā he type o ka maʻi type a ʻo ka maʻi lā 2 paha, hiki ke hoʻopiʻi ka hoʻopiʻi mai nā palu (ʻo nā nephropathy diabetes), ka ʻōnaehana cardiovascular a me ka gastrointestinal tract (autonomic neuropathy), a laila, pono ʻoe e nānā pono aku ma mua o ke kuhikuhi ʻana i nā lāʻau lapaʻau e hōʻemi i ke kaumaha. ma mua o nā mea maʻi me ka maʻi maʻi ʻole.
ʻEhā mau pūʻulu nui o nā lāʻau lapaʻau no ka pohō kaumaha
1. Nānā i nā lāʻau lapaʻau - sibutramine (inoa inoa Reduxin, Goldline).
Ke ʻano o ka hana o ka lāʻau lapaʻau: selection inhibition of serotonin and norepinephrine reuptake, ma kahi ʻāpana dopamine i loko o ka lolo. Mahalo i kēia, paʻa ka manaʻo o ka pōloli, e hoʻoulu ʻia ana e ka thermogenesis (nalowale ka wela), ke makemake nei kahi neʻe e neʻe ikaika - ke holo aku nei mākou i ke aʻo ʻana me ka leʻaleʻa.
- Hoʻomaʻa ka lāʻau lapaʻau i ka ʻāʻuhane olakino: ʻoi aku ka nui o ka hoʻomaikaʻi ʻana i ke ʻano, ke kaumaha o ka ikaika. Loaʻa i kekahi poʻe maʻi ka hoʻomau, he ʻano makaʻu.
- Hoʻomaopopo pinepine ʻia ka haunaele hiamoe: ʻaʻole makemake ke kanaka e hiamoe, ʻaʻole hiki ke hiamoe no ka lōʻihi, a ala kekahi i ke kakahiaka nui.
- He nui nā contraindications a Sibutramine. (kahi kikoʻī o ka puʻuwai, hōʻili, nā ʻōnaehana o ka puni) a me ka nui o nā hopena ʻokoʻa, no laila ua lawe ʻia ma lalo o ka nānā ʻana o kekahi kauka. I kūʻai ʻia e ka lāʻau lapaʻau.
- Ma ka maʻi mellitus, hiki i ka sibutramine ke hana i ka hoʻomaka ʻana o ka hypoglycemia (kaila koko haʻahaʻa) ma muli o ka hoʻonui ʻana o ka pākuʻina metabolic a me ka hoʻonui ʻana i ka hana kino, no laila, i ka wā e hoʻohana ai i ka lāʻau, ʻoi aku ka nui o ka mālama glycemic a, ʻoiaʻiʻo, e hoʻoponopono ʻia ka hopena hypoglycemic a me ka endocrinologist e pono ai.
2. Nā mea huna lipase - orlistat (nā inoa kālepa o Listat, Xenical).
Ke ʻano o ka hana o ka lāʻau lapaʻau: ka hoʻokaʻawale ʻokoʻa o nā enzymes e hoʻoili i nā momona i ka pā ʻo gastrointestinal. A ʻo kahi hopena, ʻaʻole i komo i ka hapa o ka momona (ma kahi o 30%, a hiki i ka nui o 50%), akā puka mai me nā feces, no kēlā me kēia, nalowale mākou i ke kaupaona a emi ka pae ʻana o kā mākou kolamu.
- ʻO ka hopena koʻikoʻi ka mea hiki ke kīleʻaleʻa. Inā mākou e overeat momona, ʻaʻole i huʻa ʻia nā momona, ʻoiaʻiʻo, aia kahi maʻi. Ma nā ʻōlelo o ka maʻi maʻi, makemake wau i ka leafa, no ka mea he stool stool - ke paʻa arabic ka waiwai, no laila ke ʻano iki ka hele ʻana o ka keʻakeʻa inā hoʻohana ʻia ka leafa.
- Kau ʻia ka lāʻau lapaʻau e kahi kauka, kūʻai ʻia ʻole me ke ʻano ʻole.
- Ma ka maʻi mellitus, he mea maikaʻi loa ka lāʻau lapaʻau ma muli o kona hiki ke hoʻohaʻahaʻa i ka kolamu koko (no ka mea, ua maʻi pinepine ka poʻe maʻi me ka maʻi maʻi i ka cholesterol kiʻekiʻe), a ma muli hoʻi i kā lākou hana haʻahaʻa (hana ia i ka lumen o ka gastrointestinal tract me nā hopena systematic ( hopena pololei) ma luna o nā kīʻaha koko, nā ʻōpū, ka puʻuwai, ʻo ia hoʻi, palekana.
Hiki i nā lipers blockase ke hoʻohana no ka maʻi diabetes a me ke ʻano type 1 a me 2.
3. nā kikoʻī o GLP-1 (e like me ka peptide-like pona o ka glucagon-1) - liraglutide (inoa inoa kālepa Saksenda - kahi lāʻau lapaʻau i hoʻopaʻa ʻia no ka mālama ʻana i ka momona, a me Victoza - nā meleaglutide like i hoʻopaʻa inoa no ka mālama ʻana i ka maʻi mellitus type 2).
Ke ʻano o ka hana o ka lāʻau lapaʻau: liraglutide - kahi mea hoʻohālike o kā mākou mau puhaka o ka mauʻu (analogue o GLP 1), ka mea i hoʻoili ʻia ma hope o ka ʻai ʻana a me ka poloka i ka pōloli (ma hope o lākou ʻaʻole makemake mākou e ʻai i nā momona momona a me nā momona)
- Ma kēia lāʻau lapaʻau, ʻike nā mea maʻi, ua kīpī ko lākou makemake no ka momona a me ka momona.
- E kōkua ka lāʻau lapaʻau e hōʻemi i ke kaumaha o ke kino ma muli o ka momona o ke ake, ʻo ia hoʻi, e nalo nui ana mākou i ke kaupaona. Ma hope o ka hoʻohana ʻana i ka lāʻau lapaʻau, hoʻohuli ʻia ke ʻano o ka nani.
- Ke hana nei ka lāʻau lapaʻau ma kekahi kaupaona - ma kahi o 120 kg, ma kahi liʻiliʻi he 62 - i kekahi hihia, inā koho ʻoe i ka ʻawa kūpono a hoʻoponopono liʻiliʻi i ka meaʻai, liʻiliʻi ka hopena.
- Maʻa ka lāʻau, akā kūʻai ʻia a loaʻa nā contraindications, ʻo nā mea nui ka maʻi pancreatitis, nā māla a me ka palaualelo.
- ʻO ka hopena koʻikoʻi kahi haʻahaʻa o ka paila. Inā, ma ka kua o ke kāwake ʻana i ka liraglutide, ua ʻai ʻoe i ka momona a me ka momona nō hoʻi, ʻoi loa ia i ke ahiahi, hiki iā ʻoe ke ʻeha loa, a ʻanoʻiʻai ʻole. ʻO kekahi mau mea maʻi e like me kēia hopena - ʻekolu auhea iā lākou, ʻaʻole makemake wau e uhai i ka meaʻai.
- Kau ʻia ka lāʻau lapaʻau e kahi kauka, kūʻai ʻia ʻole me ke ʻano ʻole. Koho ʻia ka lā wai e nā kauka - he paʻakikī loa ia ke koho kūʻokoʻa i ke kūweʻe ʻana.
- Ke lawe ʻia nei ka lāʻau lapaʻau, ʻike ʻia ka ʻano o nā puʻuwai, nā ʻōpū a me nā mea ʻē aʻe e like me ka ʻōlelo ʻana a ke kauka.
- No ka poʻe maʻi me ka maʻi diabetes, Lyraglutide a me nā mea hoʻohālike o lākou e hoihoi ai i ko lākou hopena i ke kiʻekiʻe o ka glycemia (koko koko) i hōʻike ʻia e like me ka paona. No laila, ʻo kēia lāʻau lapaʻau kekahi o nā lāʻau lapaʻau maikaʻi loa i nā maʻi me nā maʻi maʻi type 2. Me ka maʻi type type 1 ʻaʻole i pili!
4. Ka mea pinepine i ka mālama ʻana i ka momona, inā i hui pū ʻia e ka kū ʻana o ke ahonui, ʻo ia wale nō ke ʻano o ka maʻi diabetes metformin (kālepa inoa Siofor, Glucofage).
Loaʻa ka paleʻana i ka insulin ma ka 80-90% o nā maʻi maʻi momona, no laila, hoʻohana pinepine ʻia kēia lāʻau lapaʻau i ka mālama ʻana o ka momona i nā mea maʻi me ka maʻi ʻole.
Ke hana o ka hana o ka metformin: hoʻonui mahui i ka insulin, hoʻomaikaʻi i ka metabolism a me ka hoʻōho maʻamau o ka microbiota (microflora ma ka gastrointestinal tract). Ma muli o kēia, ua hōʻemi iki ka paona o ke kino a ua hoʻōla ʻia ka kō. Inā he koko maʻamau ke ʻano, ʻaʻole ia e loli. Inā hoʻokiʻekiʻe ke kō, e hoʻokiʻu iki.
- ʻO nā kumulau nui e lawe i ka metformin ke hoʻoemi nei i ka ate, kidney, anemia, a me ka maʻi ʻehaʻeha.
- ʻO ka hopena koʻikoʻi ka hana ʻino i nā lā mua a, me ka hoʻohana ʻana i ka manawa lōʻihi, he hemahema o nā B vitamina (inā inu mākou i ka metformin no ka manawa lōʻihi, hoʻohana mākou i nā vitamina B i nā manawa 2 i kēlā me kēia makahiki).
- Kau ʻia ka lāʻau lapaʻau e kahi kauka, kūʻai ʻia ʻole me ke ʻano ʻole.
Hiki i kēia mau lāʻau ke hoʻohana pū kekahi a hui pū ai me kekahi a me nā poʻe ʻē aʻe o nā lāʻau lapaʻau (no ka mālama ʻana i ka maʻi mellitus no ka maʻi pono, e hoʻomaʻamaʻa i ka hana o ke akea, nā pēpē, a me nā mea kanu).
Loaʻa kahi hui maikaʻi me ka hui pū me nā lāʻau lapaʻau e hōʻemi i ka paona me nā detox, sorbents, nā mea lapaʻau e hoʻomaikaʻi ai i ka hana o ka ate.
ʻO wai nā lāʻau e koho ai no ka pohō kaumaha i T1DM, a no T2DM kēlā?
Me ka maʻi maʻi maʻi 1 nā mea kikowaena kikowaena a me ka lipase blockers makemake ʻia. ʻAʻole hoʻohana ia ʻo Metformin no ka maʻi laʻana 1, no ka mea, ʻo ia kekahi o kāna mau hana nui, ʻo ka mālama ʻana i ka kūʻē o ka insulin, a hiki ʻole nō hoʻi i ka maʻi diabetes. ʻAʻole hoʻohana ʻia nā ʻōmole o ka GLP 1 me ka maʻi diabetes 1.
Me DM 2 ʻOi aku ka maʻalahi o nā mea maʻalahi o ka GLP 1 a me ka metformin (ʻoiai mākou e hana pū me nā pale kūpiopio a me ke kaupaona ʻana). Akā hiki nō naʻe ke hoʻohana ʻia nā lāʻau lapaʻau ma waena me ka lipase blockase, ʻo ia hoʻi, me ka maʻi maʻamau ʻoi aku ka 2 o ka hoʻohana ʻana i nā lāʻau lapaʻau.
ʻO kekahi hui pū me nā lāʻau lapaʻau i koho ʻia e ke kauka ma hope o ka hoʻopaʻa ʻana.
⠀⠀⠀⠀⠀
Olakino, ka nani a me ka hauʻoli iā ʻoe!
